Jin, D., Qian, L., Xia, J., Zhang, R., Yang, G., Zhang, L., . . . Chen, H. (2023). In vivo detection demonstrates circulating tumor cell reduction instead of baseline number has prognostic value in bladder cancer patients receiving neoadjuvant chemotherapy. Cellular Oncology, 46(3), 793. https://doi.org/10.1007/s13402-023-00785-x
Chicago Style (17th ed.) CitationJin, Di, et al. "In Vivo Detection Demonstrates Circulating Tumor Cell Reduction Instead of Baseline Number Has Prognostic Value in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy." Cellular Oncology 46, no. 3 (2023): 793. https://doi.org/10.1007/s13402-023-00785-x.
MLA (9th ed.) CitationJin, Di, et al. "In Vivo Detection Demonstrates Circulating Tumor Cell Reduction Instead of Baseline Number Has Prognostic Value in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy." Cellular Oncology, vol. 46, no. 3, 2023, p. 793, https://doi.org/10.1007/s13402-023-00785-x.